6th Annual Meeting Supporters

This educational activity is supported in part by unrestricted educational grants from the following supporters

Platinum Supporters

Novartis Pharmaceuticals
Novartis is a world leader in the research and development of products to protect and improve health and well-being. Novartis was created in 1996 from the merger of the Swiss companies, Ciba and Sandoz.

Our core businesses are in pharmaceuticals, consumer health, generics, eye-care, and animal health. Our name, derived from the Latin novae artes, meaning “new skills,” reflects our commitment to focus on research and development to bring innovative new products to the communities we serve.

In 2002, the Group’s businesses achieved sales of $20.9 billion USD and a net income of $4.7 billion USD. The Group invested approximately $2.8 billion USD in Research & Development. Headquartered in Basel, Switzerland, Novartis Group companies employ about 72,900 people and operate in over 140 countries around the world.

Gold Supporters

AstraZeneca
AstraZeneca (NYSE:AZN) is a major international healthcare business engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales over $16.4 billion and leading positions in sales of gastrointestinal, oncology, anesthesia (including pain management), cardiovascular, central nervous system (CNS) and respiratory products. In the United States, AstraZeneca is an $8.7 billion healthcare business with more than 10,000 employees.

Aventis Pharamceuticals
Aventis Pharma AG is the pharmaceutical company of Aventis. Aventis Pharma is dedicated to treating and preventing human disease through the discovery, development, manufacture and sale of innovative pharmaceutical products aimed at satisfying unmet medical needs. Aventis Pharma focuses on important therapeutic areas such as cardiology, oncology, infectious diseases, arthritis, allergies and respiratory disorders, diabetes and the central nervous system disorders. Aventis Pharma has its corporate headquarters in Frankfurt, Germany.

Schwarz Pharma
SCHWARZ PHARMA is a multinational pharmaceutical company. We strive to serve unmet medical needs by developing and marketing innovative products for specialty markets. We are committed to providing excellent services to our customers and creating significant value for our investors. SCHWARZ PHARMA has an established reputation for excellence in cardiology and is extending its focus to include the development of innovative products for urological and neurological diseases. Within neurology, our therapeutic focus includes Parkinson’s disease, restless legs syndrome, neuropathic pain and epilepsy. At the company, all development projects are coordinated globally between functional bases in Monheim, Germany, Shannon, Ireland, Tokyo, Japan and Research Triangle Park, North Carolina, USA. SCHWARZ PHARMA undertakes worldwide search activities as well as preclinical and clinical drug development. The company has a proven track record that includes four US NDAs in four years, as well as multiple approvals across Europe.

Silver Supporters

Biogen
Cephalon
Eli Lilly
GlaxoSmithKline
INC Research
Merck Research Laboratories
Teva Pharmaceutical Industries Ltd.

Bronze Supporters

Amgen
Fujisawa Healthcare
H. Lundbeck A/S

.